Celgene invests significant resources into creating disease-altering therapies for cancers. Hundreds of clinical studies around the world use our innovative treatments.
The safety and efficacy of the agents and/or uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.
aTrial conducted by licensee partner, Taiho Pharmaceuticals Co. Ltd.
Please Keep Me Informed
Provide your email address to receive monthly updates on Celgene’s research, news, and developments.
To view To return to www.researchoncology.com